- Name: Naglazyme
- Generic Name: Galsulfase
- Dosage Form & Strength: 5 mg/5 mL (1 mg/mL) single-dose vial
- Manufactured: BioMarin Pharmaceutical Inc.
Naglazyme is a hydrolytic lysosomal glycosaminoglycan (GAG)-specific enzyme.
Mucopolysaccharidosis VI (also known as MPS VI Maroteaux-Lamy syndrome). It is a rare metabolic disorder in which the body cannot produce certain sugar molecules called glycosaminoglycans.
Note: Naglazyme (Galsulfase) is an FDA-approved medicine.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.